Literature DB >> 21187455

A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma.

Vladimir Bobek1, Katarina Kolostova, Daniela Pinterova, Grzegorz Kacprzak, Jaroslaw Adamiak, Jerzy Kolodziej, Michael Boubelik, Martina Kubecova, Robert M Hoffman.   

Abstract

We report a syngeneic model of spontaneous metastatic B16-F10 mouse melanoma in C57/BL6 mice with a very high metastatic frequency that mimics clinical metastatic melanoma. The B16 melanoma cells were injected between the skin and cartilage on the dorsal side of the ear. The model generated lymphatic and visceral metastases in all of the tested animals. In mice with large primary tumors, tumor weight correlated with the tumor growth time and also with the number of metastases in lymph nodes and organs. The dorsal ear space between the skin and cartilage enables both lymphatic and hematogenous metastatic spread. The model should be useful to study the mechanism of melanoma metastasis and to develop therapy for this currently untreatable disease.

Entities:  

Mesh:

Year:  2010        PMID: 21187455

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  24 in total

1.  Lymph node biophysical remodeling is associated with melanoma lymphatic drainage.

Authors:  Nathan Andrew Rohner; Jacob McClain; Sara Lydia Tuell; Alex Warner; Blair Smith; Youngho Yun; Abhinav Mohan; Manuela Sushnitha; Susan Napier Thomas
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

2.  Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma.

Authors:  Elena I Deryugina; William B Kiosses
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

Review 3.  Prioritizing therapeutic targets using patient-derived xenograft models.

Authors:  K A Lodhia; A M Hadley; P Haluska; C L Scott
Journal:  Biochim Biophys Acta       Date:  2015-03-14

4.  Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.

Authors:  Kiyoto Takehara; Shuya Yano; Hiroshi Tazawa; Hiroyuki Kishimoto; Nobuhiro Narii; Hiroyuki Mizuguchi; Yasuo Urata; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-01-05       Impact factor: 4.534

5.  Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Authors:  Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-04-24       Impact factor: 3.325

Review 6.  Rebuilding cancer metastasis in the mouse.

Authors:  Meera Saxena; Gerhard Christofori
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

7.  Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.

Authors:  Nadezhda L Mironova; Irina Y Petrushanko; Olga A Patutina; Aexandra V Sen'kova; Olga V Simonenko; Vladimir A Mitkevich; Oleg V Markov; Marina A Zenkova; Alexander A Makarov
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

8.  A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Authors:  Rajesh K Sharma; Zinal S Chheda; Biswa Pratim Das Purkayastha; Jorge G Gomez-Gutierrez; Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  Clin Exp Metastasis       Date:  2015-12-15       Impact factor: 5.150

Review 9.  Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.

Authors:  Soledad Mac Keon; María Sol Ruiz; Silvina Gazzaniga; Rosa Wainstok
Journal:  Front Immunol       Date:  2015-05-20       Impact factor: 7.561

Review 10.  Current State of Animal (Mouse) Modeling in Melanoma Research.

Authors:  Omer F Kuzu; Felix D Nguyen; Mohammad A Noory; Arati Sharma
Journal:  Cancer Growth Metastasis       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.